The Leprosy Mission's ILC 2022 Oral Presentation Timetable

ILCABS832: Whole-Genome Tiling Array Analysis of M. Leprae in leprosy patients from India

ILCABS295: Adverse Effect of thalidomide in chronic ENLs among patients affected with leprosy

ILCABS355: A Study on improvement of Quality of life among Leprosy affected people in endemic districts in Nepal

Innovation session - TLM

ILCABS331: Cohort Study to understand the status of M. Leprae viability and its positivity in nost of leprosy patients after one dose of multridrug regimen

ILCABS:131: Applicability of the findings from Job Characteristics Model in the context of leprosy institutions and treatment towards achieving zero leprosy in India

Lead Talk: What's New in the Immunology of Leprosy?

ILCABS625: Leprosy in children

ILCABS60: The missing thousands: bridging the gender gap in leprosy case detection

ILCABS627: Effect of COVID-19 on leprosy case detection in urban and rural contexts in Bangladesh

ILCABS766: Prevalence of leprosy ulcer and its profile in the community

ILCABS544: Prevalence of plantar ulcer and its risk factors in leprosy: a syctematic review and meta-analysis

ILCABS512: Trend of drug resistance in M. leprae isolates from relapsed leprosy patients from 2018-2021

ILCABS857: Study of drug resistance in M. leprae isolates from reactional leprosy patients

ILCABS231: Genome-wide analysis of drug resistant M. leprae strains isolated from leprosy patients

ILCABS199: An individual randomised efficacy trial of Autogolous Blood products, Leucocyte and Platelets Rich Fibrin (L-PRF) to promote ulcer healing in leprosy (TABLE TRIAL)

ILCABS346: Role of improved healthcare access towards zero leprosy

ILCABS271: Do mimicking T-cell epitopes (peptides) between M. leprae and host proteins evoke automimmune reactions leading to the pathogenesis of reactions in leprosy

ILCABS777: Impact of COVID-19 on access to healthcare, livelihood and education among persons affected by leprosy

ILCABS590: Can elgible persons affected by leprosy and their families contribute in zero leprosy

ILCABS528: Leadership role of persons affected by leprosy in the lives of Self0Help Groups (SHG) members

ILCABS883: Childhood Leprosy: A retrospective descriptive study from a tertiary hospital

ILCABS145: Revisiting the Slit Skin Microscopy for diagnosis and early detection of leprosy

ILCABS862: Leprosy and Spil-Transmitted Helminths Part 1: Indicators and Clinical Outcomes

ILCABS752: A signlecenter, open label pilot study to evaluate the safety and efficacy of CC-11050, a novel phosphodiesterase-4 inhibitor, in Nepalese atients with Erythema Nodosum Leprosum

Lead Talk: Reconstructive surgery to reverse deformities in leprosy

ILCABS204: Retrospective review of leprosy relapse clinical profiles

ILCABS450: The situation of grade 1 disability in leprosy after RFT in Bangladesh

Lead Talk: Repealing discriminatory laws - Are we there yet?

Lead Talk: Innovation in disability dare in leprosy - use of a mobile thrapy unit

ILCABS183: 3D printing technology in leprosy rehabilitation

ILCABS413: Impact of a mobile therapy unit approach for individuals with leprosy and other disabilities in rural areas in Tamil Nadu

Lead Talk: Management of leprosy at sub-national level - Experience from a hyperendemic block in North India

ILCABS311: Honey Experimental on LeProsy Ulcer (HELP): A randomised control trial of raw, unadulterated Africa Honey for ulcer healing in leprosy

ILCSABS138: Organizing and manageing a programme for self-care in leprosy

ILCABS406: Understanding the livelihood aspirations, occupational and skills preferences of persons affected by leprosy/disability n the districts Prayagraj and Barabanki of Uttar Pradesh and Jangir Champa in Chhattisgarh.

ILCABS5: Mainstreaming leprosy disabled through Disabled People Organization in Bangladesh

ILCABS532: A study on the prevalence of disability among people affected by leprosy in a leprosy endemic district

ILCABS64: Enhancing Leprosy Expertise: A New Leprosy Competencies Framework

Lead Talk: Ocular Leprosy - Changing Profiles & Priorities

ILCABS407: Temporalis Muscle Transfer for paralytic lagophthalmos reconstruction in leprosy

ILCABS623: Distant registration scenario in Bangladesh: Facing the realities to leprosy control

ILCABS286: Migration and its risk associated with leprosy among new cases diagnosed in a tertiary care centre in Chhattisgarh

ILCABS519: What is truth? Zero leprosy or zero reports!

ILCSABS246: Absolute quantification for assessment of viable load of M. leprae in high BI leprosy patients treated with MDT regimen

ILCABS227: School dropouts among leprosy affected: need for follow-up of cases, reasons and counselling